Results 11 to 20 of about 825,404 (299)

Evaluation of Properties of Dexamethasone Eye Drops

open access: yesEuropean Pharmaceutical Journal, 2023
During the development of medicinal forms (eye drops), it is necessary to consider several parameters, so that the medicine is nonirritating to the eye and, at the same time, has the desired effect.
Matušová D.   +3 more
doaj   +2 more sources

How to prepare chlorhexidine eye drops. [PDF]

open access: yes, 2023
Chlorhexidine eye drops can be used for the treatment of fungal keratitis as a second line therapy where natamycin eye drops are not available. Chlorhexidine eye drops typically used in the clinic are prepared by diluting a concentrated solution of ...
Mohamed-Ahmed, Abeer HA   +2 more
core   +4 more sources

Parents' views on their children's use of eye drops and willingness to accept a new sustained-release subconjunctival injection

open access: yesClinical Ophthalmology, 2017
Semra Ozdemir,1,* Hong King Wu,1,* Eric A Finkelstein,1 Tina T Wong2 1Signature Program in Health Services and Systems Research, Duke-NUS Medical School Singapore, 2Glaucoma Department, Singapore National Eye Centre, Singapore *These authors ...
Ozdemir S   +3 more
doaj   +1 more source

Local production of eye drops in the hospital or pharmacy setting: considerations and safety tips. [PDF]

open access: yes, 2023
Most eye medicines for topical use are prepared by pharmaceutical companies using special automated mixing and filling machines. However, some eye drops can be prepared in a pharmacy setting in a hospital. There are several reasons1,
Mohamed-Ahmed, Abeer HA   +1 more
core   +4 more sources

A very early steroid responder after cataract surgery: a case report

open access: yesBMC Ophthalmology, 2023
Background Increased intraocular pressure (IOP), a side effect of corticosteroid eye drops, typically develops during the first few weeks of administration, and steroid response is not generally considered a cause of increased IOP immediately after ...
Atsushi Kawahara
doaj   +1 more source

NSAIDs eye drops versus steroidal eye drops after phacoemulsification cataract surgery

open access: yesDelta Journal of Ophthalmology, 2018
Purpose The aim of this study was to evaluate the efficacy NSAID eye drops in comparison with topical steroids following phacoemulsification cataract surgery. Patients and methods This prospective study included 120 patients with senile cataract who were
Safaa A.M Aboud
doaj   +1 more source

Assessing the Impact of Sodium Hyaluronate Eye Drops on the Ocular Surface Microbiome: Implications for Dry Eye Management and Ocular Health : Eye Microbiome [PDF]

open access: yes, 2021
: Background: A powerful immunoregulatory function is provided by the ocular surface microbiome, which contributes to ocular pathogenesis, physiological integrity, and pathogenesis of ocular diseases. Using sodium hyaluronate eye drops (with or without a
Kavianfar, Azadeh   +2 more
core   +1 more source

Ophthalmic and anesthetic evaluation of topical 1% tetracaine and 0.5% proparacaine in dogs

open access: yesArquivo Brasileiro de Medicina Veterinária e Zootecnia, 2011
The aim of this study was to establish the action of 1% tetracaine eye drops in combination with 0.1% phenylephrine in two different posologies and their effects on the eye compared to the 0.5% proparacaine drops in dogs. 22 animals were divided into two
H.D. Parchen   +6 more
doaj   +1 more source

The effect of loteprednol suspension eye drops after corneal transplantation

open access: yesBMC Ophthalmology, 2021
Background To compare the effect of loteprednol suspension eye drops after corneal transplantation with the effect of prednisolone acetate eye drops. Methods A total of 234 patients (234 eyes) who underwent penetrating keratoplasty (PKP) and lamellar ...
Yingxin Chen   +4 more
doaj   +1 more source

A Patient with Corneal Epithelial Disorder That Developed after Administration of a Latanoprost Generic, but Not a Brand-Name Drug, Eye Drop

open access: yesCase Reports in Ophthalmological Medicine, 2012
Background. We report a patient who developed corneal epithelial disorder repeatedly after changing the prescription from Xalatan eye drops (Pfizer Inc.) to Latanoprost eye drops (Kaken Pharmaceutical Co., Ltd.), both containing 0.005% latanoprost. Case
Yukihisa Takada   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy